These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18922938)

  • 1. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Methylation Analysis of the PCDHB Gene Cluster.
    Banelli B; Romani M
    Methods Mol Biol; 2015; 1315():189-200. PubMed ID: 26103900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development.
    Liang P; Song F; Ghosh S; Morien E; Qin M; Mahmood S; Fujiwara K; Igarashi J; Nagase H; Held WA
    BMC Genomics; 2011 May; 12(1):231. PubMed ID: 21569359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
    Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
    FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
    Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
    Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered protocadherins methylation alterations in cancer.
    Vega-Benedetti AF; Loi E; Moi L; Blois S; Fadda A; Antonelli M; Arcella A; Badiali M; Giangaspero F; Morra I; Columbano A; Restivo A; Zorcolo L; Gismondi V; Varesco L; Bellomo SE; Giordano S; Canale M; Casadei-Gardini A; Faloppi L; Puzzoni M; Scartozzi M; Ziranu P; Cabras G; Cocco P; Ennas MG; Satta G; Zucca M; Canzio D; Zavattari P
    Clin Epigenetics; 2019 Jul; 11(1):100. PubMed ID: 31288858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placentas from pregnancies conceived by IVF/ICSI have a reduced DNA methylation level at the H19 and MEST differentially methylated regions.
    Nelissen EC; Dumoulin JC; Daunay A; Evers JL; Tost J; van Montfoort AP
    Hum Reprod; 2013 Apr; 28(4):1117-26. PubMed ID: 23343754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island hypermethylation in human astrocytomas.
    Wu X; Rauch TA; Zhong X; Bennett WP; Latif F; Krex D; Pfeifer GP
    Cancer Res; 2010 Apr; 70(7):2718-27. PubMed ID: 20233874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXD13 methylation status is a prognostic indicator in breast cancer.
    Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
    Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
    Zhou X; Chen Z; Cai X
    Epigenetics; 2018; 13(5):473-489. PubMed ID: 29940789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
    Levine JJ; Stimson-Crider KM; Vertino PM
    Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.